Company intelligence / Profile preview

Shanghai Trifecta Pharma

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai Trifecta Pharma is a long-established manufacturer and supplier of over 500 generic drugs, APIs, and medical/veterinary products, operating at commercial scale with GMP- and ISO-certified facilities. The company is focused on high-volume manufacturing and global distribution rather than clinical-stage innovation; no clinical trial data released.

Therapeutic areas: Infectious DiseasesOther
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Trifecta Pharmaceuticals USAHong Kong Trifecta Pharma LimitedNGOsgovernment agenciesprivate companies worldwide

Beyond the preview

Go deeper on Shanghai Trifecta Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Trifecta Pharma.

Explore the full profile